Expression and clinical significance of FGF-2 and hTERT in non-small cell lung cancer

VernacularTitle:非小细胞肺癌FGF-2和hTERT的表达及其临床意义
Author: Zengmei SHENG ; Chunhong HU
Publication Type:Journal Article
Keywords: Carcinoma,non-small-cell lung; Fibroblast growth factor 2; Human teclomerase reversetranscriptase
From: Journal of International Oncology 2011;38(9):717-720
CountryChina
Language:Chinese
Abstract: Objective To investigate the expression and clinical significance of fibroblast growth factor-2 (FGF-2) and human teclomerase reverse transcriptase (hTERT) in non-small cell lung cancer (NSCLC) tissues and analyze the correlation between them.Methods The expression of FGF-2 and hTERT were detected by immunohistochemistry in 90 NSCLC tissues and 20 non-lung carcinoma tissues.The correlation between the expression and clinicopathological features was also analyzed.Results The positive expressions of FGF-2(66.7％ ) and hTERT (75.6％) in NSCLC tissues were significantly higher than that in nonlung carcinoma tissues (15％ and 20％,respectively),P ＜0.01.The expression of FGF-2 and hTERT were significantly related to TNM stages and lymph node metastasis (P ＜ 0.01 ),but not to histological types,sex and age of NSCLC patients ( P ＞ 0.05 ).A positive correlation was found between the expressions of FGF-2 and hTERT in NSCLC(P ＜ 0.01 ).Conclusion The expression of FGF-2 and hTERT in NSCLC,which can be regarded as important references for prognosis of NSCLC,play important roles in the initiation and development of NSCLC.